News

The sale is believed to have achieved Clinical Data’s goal to monetize non-core assets and focus resources on advancing its two late-stage targeted therapeutic programs, each of which

Cell Therapeutics (CTI) expects to complete the submission this quarter and will request priority review which if granted could lead to an approval decision from the FDA in

In this agreement, Syntopix will make available the company’s library of compounds for evaluation of their application in a number of areas as candidates for development into commercial

US-based pharmaceutical company Pharmacyclics has initiated treatment in a Phase I dose-escalation study to evaluate the safety and tolerability of PCI-32765, an orally available, selective inhibitor of Bruton’s

Alpine Biomed, a developer of specialty diagnostic devices, has doubled its manufacturing capacity and expanded its worldwide network by opening a new facility in Vietnam. The company will

The nine-month consolidated net loss to February 28, 2009 was C$13.63 million, or C$0.10 per share, compared to a net loss of C$54.69 million, or C$0.44 per share,

The library consists of specifically designed molecules targeting key enzymes and processes involved in both cancer and viral diseases. ViroStatics will identify and develop candidate compounds with activity

Biodue will initially offer the test to customers through Italian dermatologists. The agreement makes Biodue the sole distributor of HairDX’s genetic tests in Italy, and is believed to

The FDA approval letter confirms that American Biotech Labs (ABL) may market ASAP wound dressing gel for the topical management of minor cuts, lacerations, abrasions, first and second